FALCON Breast Cancer Trial: Who ' s Naive Here? FALCON Breast Cancer Trial: Who ' s Naive Here?

In the FALCON trial, fulvestrant improved PFS in ER+ metastatic breast cancer patients who were endocrine-therapy naive, but the trial failed to answer key clinical questions, says Dr Lidia Schapira.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Viewpoint Source Type: news